Research Article
Limited Utility of Routine Surveillance MRI Following Chemoradiation for Advanced-Stage Oropharynx Carcinoma
Table 3
Primary site, staging, time to recurrence, and treatment outcome of locoregional failures.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DOD, died of disease No evidence of disease at 26 months after high-dose-rate brachytherapy and chemotherapy No evidence of disease at 25 months after neck dissection |